I.Introduction of General Surgery Base

The Department of General Surgery was established in 1958, with Professor Qian Li as one of the founders, and his book "Qianli Abdominal Surgery" was one of the earliest published monographs in the field of abdominal surgery in China, which has influenced and trained a generation of surgeons. The Department was awarded the PhD degree in 2006, and has been listed as a key discipline in Zhejiang Province, a key discipline in Zhejiang Province, a "top priority" discipline in Zhejiang Province, and a medical support discipline in Zhejiang Province.

After 60 years of development, the specialty has formed eight subspecialties, including hepatobiliary and pancreatic surgery, gastrointestinal surgery, colorectal and anal surgery, thyroid surgery, breast surgery, vascular surgery, hernia and abdominal wall surgery and trauma surgery, with a total of 780 beds and an annual surgical volume of more than 18,000 cases. It is one of the largest and most technologically complete general surgery departments in Zhejiang Province, and is also a landmark specialist medical centre in Wenzhou. At present, the specialty has formed a number of special brands such as diagnosis and treatment of malignant tumors of the digestive system, cirrhosis portal hypertension, severe acute pancreatitis, application and care of enterostomy, application of parenteral nutrition TPN, puncture biopsy of thyroid breast and superficial swelling.

The department pays great attention to talents training and team building. There are nearly 150 professional and technical personnel, including 33 doctors and more than 100 masters; 64 people with senior titles and 45 people with intermediate titles, accounting for 66.7% of the senior titles; 39.7% of the staff aged 30-50. The department has trained 57 talents at various levels, such as special experts from Zhejiang Province, national candidates for the "Hundred Million Talents Project", national young and middle-aged experts with outstanding contributions, national young and middle-aged experts with outstanding contributions to health and sanitation, and those who enjoy special allowances from the State Council.

The department insists on the collaborative development of medical education and research. It is the core unit of Zhejiang Clinical Research Centre for Minimally Invasive Diagnosis and Treatment of Abdominal Organs, Zhejiang Clinical Research Centre for Hepatobiliary and Pancreatic Diseases, National Clinical Trial Base for Drugs, Ministry of Health Training Base for Endoscopy, Ministry of Education Specialized Major Construction Point for Higher Education, and has the Key Laboratory of New Technology Research for Diagnosis and Treatment of Critical Diseases of Pancreas and Liver of Zhejiang Province, Wenzhou Key Laboratory of Surgery, Wenzhou Medical University Hepatobiliary and Pancreatic. It is also the editor-in-chief of the Journal of Hepatobiliary and Pancreatic Surgery.

In the past three years, members of the team have been awarded 21 national and 44 provincial and ministerial level projects, with a total research expenditure of more than 20 million RMB, 409 SCI-indexed papers published by the first or corresponding authors, 4 provincial and ministerial level awards (including 3 first-class awards), 10 departmental and bureau level awards, 23 edited or co-edited monographs, 9 national invention patents and 18 utility model patents, 82 national-level continuing education programs, and the development of new and innovative technologies. 82 continuing education programs and more than 10 new technologies developed.

II.Base Faculty

There are 53 qualified instructors in the base, who are licensed to teach, and each teaching physician can teach no more than 2 training subjects at the same time; all teaching physicians have a bachelor's degree or above, and have held the professional and technical position of associate chief physician for more than 3 years.

Professor Shan Yunfeng is in charge of this specialist base; the teaching director is Director Chen Zongjing, and the teaching team includes Director Yu Zhengping, Director Chen Xiaolei, Director Pan Yifei, Director Zhou Hongzhong, Director Wang Ouchen, Director Huang Jingyong, Director Chen Jicai and Director Chen Xiangjian. The profiles are as follows:

III.Head of Specialized Training Base

Shan Yunfeng, M.D., Chief Physician, Master's Supervisor, Young and middle-aged discipline leader of Zhejiang University, New Medical Talent of Zhejiang Province. He is a visiting scholar at the University of California, Los Angeles Medical Center and the University of Regensburg Medical School in Germany. He is currently the Deputy Director of the Department of Hepatobiliary Surgery and Deputy Director of the Transplantation Centre of the First Affiliated Hospital of Wenzhou Medical University. He is a youth member of the Cholangiocarcinoma Committee of the Chinese Anti-Cancer Association, a member of the Precision Medicine Branch of the Zhejiang Medical Association, a standing committee member of the Pancreatic Diseases Committee of the Zhejiang Medical Association, and a deputy director of the Youth Committee of the General Surgery Branch of the Zhejiang Association of Integrative Medicine.

He specializes in hepatobiliary and pancreatic surgery and is dedicated to the diagnosis and treatment of liver transplantation and difficult diseases of the liver, bile and pancreas. He has chaired and participated in 6 National Natural Science Foundation of China and 3 provincial and ministerial level projects including Zhejiang Provincial Natural Science Foundation. He has trained more than 10 postgraduate students. He has published more than 20 SCI-accepted papers. He has participated in the first prize of Zhejiang Provincial Science and Technology Progress Award and the first prize of Zhejiang Provincial Medicine and Health Science and Technology Award.

IV.Teaching Condition

Through the implementation of the tutor system, the base assigns tutors to trainees, communicates regularly and conducts counseling; the training objectives of the special training trainees are clear, the teaching plans are rich and varied, and the types of skills and operations are diverse. Rotation plans are strictly implemented according to the training rules of the relevant disciplines, induction education is provided at the time of entry into the subject and the attendance system is observed during training. The number of teaching activities meets national assessment standards. At the end of the month, theoretical and skills assessments are conducted at the department level for the outgoing trainees.

The Department encourages trainees to participate in various academic conferences and teaching activities. For example, the annual meeting of the Chinese Medical Association of Surgery, the Sino-Japanese Workshop on Hepatobiliary and Pancreatic Lean Diagnosis and Treatment, and the study course on the progress of evidence-based medical treatment of hepatobiliary and pancreatic tumors, to learn the latest knowledge and research progress in the general surgery specialty.

At the 20th Annual Meeting of the Chinese Medical Association of Surgery, Zheng Ru, a trainee of the base, gave a speech on "Innovative Application of Hepatic Sickle Ligament in Ventricular Drainage" at the Hepatobiliary and Pancreatic Free Forum.

During the New Coronary Pneumonia (NCP) epidemic, our specialist training instructors were actively involved in the fight against the epidemic, and our trainees gave up their Spring Festival holidays to support the fever clinic, becoming the first group of soldiers to face NCP.

I.Introduction to the Specialist Base of Intensive Care Medicine

The Department of Intensive Care Medicine was established in January 1996, and is one of the earliest departments of intensive care medicine established in China. In 2004, the department was awarded the master's degree and in 2014 it was awarded the training site for doctoral students in emergency medicine (intensive care medicine), and was listed as a medical innovation discipline in Zhejiang Province.

After 25 years of development, the specialty now has 96 beds (81 beds in the Nanbaixiang Campus and 15 beds in the Gongyuanlu Campus) and undertakes rescue missions for acute and critical illnesses and public emergencies in southern Zhejiang and northern Fujian. The number of patients admitted to the integrated ICU reached more than 2,000 in 2020.

It has accumulated much clinical experience in the treatment of acute and critical illnesses such as various types of shock, severe infection, heavy cerebrovascular accident, multiple injuries, severe craniocerebral injury, pulmonary embolism, aortic coarctation, malignant cardiac arrhythmia, acute respiratory distress syndrome, multiple organ dysfunction syndrome, organ transplantation and post-surgical organ support.

At present, it has developed a wide range of techniques including the application of advanced mechanical ventilation such as APRV and ASV, oesophageal pressure monitoring, bedside blood purification, ECMO, pulse-indicated continuous cardiac output monitoring (PICCO), Swan-Gans hemodynamic monitoring, temporary bedside pacing, fibreoptic bronchoscopy, subcritical cerebral protection, percutaneous tracheotomy, pulmonary dilation, critical care ultrasound and bedside cerebral function monitoring. The training is available to meet the training requirements of intensive care physicians for various types of diseases and operations, including percutaneous tracheotomy, pulmonary resuscitation, critical care ultrasound and bedside brain function monitoring techniques.

The specialty of intensive care medicine pays attention to the cultivation of talents and the construction of echelon. At present, there are 25 core faculty members, including 12 senior doctors, 13 associate doctors, 3 doctoral supervisors and 15 master's supervisors, with 71.7% of them aged 30-50. All of them have been engaged in clinical, research and teaching work for more than 10 years.

In the past 5 years, the intensive care medicine team has completed and undertaken 9 National Natural Science Foundation projects, 10 provincial and ministerial level projects and nearly 20 departmental level projects. He has published more than 100 SCI-indexed papers as the first or corresponding author, and his research results have won one first prize of the Chinese Medical Science and Technology Award, one second prize of the Chinese Medical Science and Technology Award, two first prizes of the Science and Technology Progress Award of the People's Government of Zhejiang Province, one second prize of the Science and Technology Progress Award of the People's Government of Zhejiang Province, one third prize of the Science and Technology Progress Award of the People's Government of Zhejiang Province, one first prize of the Medicine and Health Science and Technology Award of Zhejiang Province, and one second prize of the Medicine and Health Science and Technology Award of Zhejiang Province. He was awarded 3 national utility model patents and held dozens of national continuing education programs and provincial continuing education programs.

II.Head of Specialized Training Base

Pan Jingye, Professor, Chief Physician, Doctor of Medicine, Doctoral Supervisor. In 1996, he founded the Department of Intensive Care Medicine of the hospital and has been engaged in clinical, scientific research and teaching work in acute and critical care for a long time. He first proposed the theory of "Clustered Microcirculatory Resuscitation", and under the guidance of this theory, he has been practicing "Titration Feedback Intelligent Treatment" for many years, successfully treating a large number of patients with severe sepsis, ARDS, DIC, MODS, etc. He specializes in the non-surgical and completely conservative rescue of severe acute pancreatitis, with a very high success rate and low hospitalization costs, bringing good news to patients with severe acute pancreatitis, and is well received by patients and their families. For more than 10 years, he has served as the head of the medical treatment team for the Wenzhou H1N1 influenza A, H7N9 avian influenza, Ebola hemorrhagic fever and other public health emergencies in Wenzhou, and all the patients were survived. He is the head of the medical treatment research and analysis team of Wenzhou City and Hospital for New Coronavirus Pneumonia, and is responsible for 24-hour consultation and analysis of the city's epidemic in all counties and urban areas of Wenzhou, and is directly stationed at the front line of the isolation ward to rescue critically ill patients. He mastered and applied the key pathophysiological change mechanisms of sepsis-induced microcirculatory disorders in critically ill patients with Covid-19 and the laws of critical life mechanics changes such as power, resistance, tension and pressure of respiratory circulation and the theory of clustered microcirculatory resuscitation and treatment, flexibly applied fluid resuscitation, mechanical ventilation, blood purification, resuscitation drugs and other means of life-organ rescue, seized the nodes at critical moments, made decisive decisions on non-invasive invasive ventilation He has also decisively removed the tracheal tube in many cases of critically ill patients and withdrawn the second case of ECMO in Zhejiang Province. He led the medical and nursing team to quickly and accurately treat critically ill patients with Covid-19, with a success rate of 99%, a mortality rate of 0.2% and zero infection among medical and nursing staff. Through systematic clinical observation and generalization of autopsy results of patients with Covid-19, he proposed that "the main cause of death in patients with Covid-19 sepsis is diffuse alveolar damage (DAD) combined with diffuse intravascular coagulation (DIC)", which was published in the journal Biological Procedures Online in January 2021. Biological Procedures Online, which provides new expert insights into the imbalance of the coagulation system in patients with severe Covid-19 sepsis.

He is currently a member of the Professional Committee of Intensive Care Medicine of the Chinese Medical Association, a member of the Intensive Care Medicine Branch of the Chinese Medical Association, a member of the Professional Committee of Intensive Care Medicine of the Chinese Society of Pathophysiology, a deputy director of the Professional Committee of Intensive Care Medicine of the Zhejiang Medical Association, a director of the Professional Committee of Intensive Care Medicine of the Wenzhou Medical Association, a director of the Quality Control Centre of Intensive Care Medicine of Wenzhou, Head of the virtual laboratory of AI-assisted diagnosis and treatment and medical ethics training scenario simulation for general practice Internet medical reception of the Ministry of Education, head of the key laboratory of intelligent treatment and life support for critical illnesses in Zhejiang Province, and head of the Collaborative Innovation Center for Intelligent Medical Education in Wenzhou. He is also the leader of the discipline of critical trauma treatment in Zhejiang Province, a distinguished talent of the "Ten Thousand People Plan" in Zhejiang Province, a distinguished talent of the Wenzhou High-level Talents Special Support Program, the honorary title of "Excellent Professional Base Director" of the 2018 National Residency Training, and a recipient of the State Council Government Special allowance.

He has led 3 projects of the National Natural Science Foundation of China, the joint project of National Health and Health Commission-Zhejiang Provincial Health and Health Commission, major science and technology special projects of Wenzhou Science and Technology Bureau, Zhejiang Provincial Natural Science Foundation, Zhejiang Provincial Science and Technology Department and many other projects. He has published more than 70 SCI and Medline papers and more than 200 Chinese papers, 12 monographs and 3 patents. He has trained more than 70 PhD students. He was awarded one first prize of Science and Technology Progress Award of the People's Government of Zhejiang Province, two third prize of Science and Technology Award of Zhejiang Province, one first prize of Medicine and Health Science and Technology Award of Zhejiang Province, two second prize of Medicine and Health Science and Technology Innovation Award of Zhejiang Province, and one second prize of Science and Technology Progress Award of Wenzhou Municipal People's Government.

I.Introduction to the Specialist Base of Pulmonary and Critical Care Medicine

The Department of Pulmonary and Critical Care Medicine (PCCM) of the First Hospital of Wenzhou Medical University is a doctoral and master's degree awarding unit, a medical support discipline of Zhejiang Province, an innovative discipline of Zhejiang Province, a training base for respiratory endoscopy of the National Health Planning Commission, a base for clinical drug trials in respiratory medicine, a training base for pilot specialists in respiratory and critical care medicine of the Chinese Medical Association, a core member of the National Respiratory Clinical Research Centre, the first batch of special training bases of the national PCCM and a single training base.

There are now 190 beds, including 27 RICU beds. The clinical focus is on lung cancer and respiratory interventional techniques, diagnosis and treatment of respiratory critical illnesses and respiratory tract infections, and chronic airway diseases; a comprehensive range of diagnostic and therapeutic respiratory interventional techniques, including silicone stent placement for complex airway stenosis and interventional techniques for benign inflammatory airway disease. The department is ranked among the top ten in China for respiratory interventional techniques. The Department has a key laboratory of interventional pulmonology in Zhejiang Province, a key laboratory of molecular biology of Chinese medicine in Zhejiang Province, a key laboratory of respiratory circulation in Wenzhou and a key laboratory of interventional pulmonology in Wenzhou.

The PCCM department has 25 core faculty members covering various sub-specialties of PCCM medicine: infection, respiratory intensive care, lung cancer, respiratory intervention, pulmonary vascular disease and chronic airway disease, interstitial lung disease and critical care, emergency medicine and anesthesia. The core faculty includes three doctoral supervisors, nine master's supervisors and seven medical doctors. Among the members of the department, there is one young and middle-aged expert with outstanding contribution from the National Health Care Commission, one expert with special allowance from the State Council, one young and middle-aged scientific and technological talent with outstanding contribution from Zhejiang Province, two high-level innovative talents from Zhejiang Province, two young and middle-aged leaders of disciplines from Zhejiang Province, five 151 talents from Zhejiang Province and six 551 talents from Wenzhou City. Since 2008, it has been awarded 12 national natural funds and 10 provincial and ministerial level projects, and has published more than 200 SCI papers.

The research focuses on the pathogenesis and prevention of pulmonary hypertension, the molecular mechanism of Staphylococcus aureus and the molecular mechanism of acute respiratory distress syndrome. The research on the molecular mechanism of Staphylococcus aureus and the molecular mechanism of acute respiratory distress syndrome led by Prof. Wang Liangxing won the First Prize of Chinese Medical Science and Technology Award and the First Prize of Zhejiang Provincial Government Science and Technology Award in 2011. The research on the molecular mechanism of chronic pulmonary hypertension and the integrated prevention and treatment of Chinese and Western medicine" led by Professor Huang Xiaoying won the second prize of the Chinese Medical Science and Technology Award in 2017. In 2017, the project "Bioinformatics-based Research on Risk Factors, Etiology and Pathogenesis of Chronic Obstructive Lung Disease" led by Prof. Chen Chengshui, the project leader, was awarded a special grant from the Ministry of Science and Technology of the People's Republic of China for the 13th Five-Year Plan "Research on Prevention and Control of Major Chronic Non-communicable Diseases". Professor Chen Chengshui's project "New Discovery of the Pathogenesis of Acute Lung Injury and its Technological Innovation and Application in Diagnosis and Treatment" won the Second Prize of Zhejiang Provincial Science and Technology Progress and the Special Prize of Zhejiang Provincial Medicine and Health in 2018.

II.Head of Specialized Training Base

Li Yuping, professor, chief physician, master's tutor, is currently a member of the Infection Group of the Respiratory Branch of the Chinese Medical Association, a member of the Respiratory Branch of the Zhejiang Medical Association, deputy head of the Critical Care Group of the Respiratory Branch of the Zhejiang Medical Association, a member of the Standing Committee of the Association of Metabolic Reactions of the Zhejiang Medical Association, a member of the Standing Committee of the Professional Committee of Lung Cancer of the Chinese Medical Education Association, and director of the Department of Pulmonary and Critical Care Medicine of the First Affiliated Hospital of Wenzhou Medical University. She has been engaged in the clinical practice of respiratory medicine for 31 years and has been devoted to clinical, teaching and scientific research work. She specializes in the diagnosis and management of respiratory tract infections and respiratory intensive care, lung cancer diagnosis and treatment and difficult respiratory diseases. She participated in the development of the 2016 Chinese Guidelines for Community Acquired Pneumonia (CAP) in Adults and the Chinese Guidelines for the Diagnosis and Treatment of HAP/VAP Pneumonia in Adults.